Neurologic complications of illicit drug abuse

CONTINUUM Lifelong Learning in Neurology

Volumn 20, Issue 3, 2014, Pages 642-656

  Brust, John C M ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 HYDROXYBUTYRIC ACID; CANNABIS; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; ILLICIT DRUG; INHALANT; METHCATHINONE; OPIATE; PHENCYCLIDINE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; AGITATION; ATAXIA; ATAXIC GAIT; BEHAVIOR; BRAIN DISEASE; BRAIN INJURY; BRAIN SPONGIOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR ACCIDENT; COGNITION; COMA; CONJUNCTIVAL DRUG ADMINISTRATION; CONSTIPATION; COUGHING; DELUSION; DEPERSONALIZATION; DEPRESSION; DIARRHEA; DIZZINESS; DRUG ABUSE; DRUG INTOXICATION; DYSARTHRIA; DYSMETRIA; EUPHORIA; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPERTENSIVE CRISIS; HYPOTHERMIA; INCREASED APPETITE; INSOMNIA; LACRIMATION; LIBIDO DISORDER; MACROCYTIC ANEMIA; MALIGNANT HYPERTHERMIA; MEMORY DISORDER; MIOSIS; MOTOR DYSFUNCTION; MYALGIA; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NERVOUSNESS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PARANOIA; PARKINSONISM; PERIPHERAL NERVE INJURY; PRURITUS; QUADRIPLEGIA; REFLEX; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; RHINORRHEA; SEIZURE; SPINAL CORD INJURY; SUICIDAL IDEATION; SWEATING; SYSTOLIC HYPERTENSION; TACHYCARDIA; TREMOR; UNSTEADINESS; VISUAL HALLUCINATION; VOMITING; WHITE MATTER; WITHDRAWAL SYNDROME; YAWNING;

EID: 84902161191     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000450971.99322.cd     Document Type: Review

References (63)

1. Brust JCM. Neurological aspects of substance abuse. 2nd ed. Philadelphia: Elsevier Butterworth Heinemann, 2004.
2. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdosesVa U. S. epidemic. MMWR Morb Mortal Wkly Rep 2012;61(1):10-13.
3. Skowronek R, Celinski R, Chowaniec C. ''Crocodile''Vnew dangerous designer drug of abuse from the East. Clin Toxicol (Phila) 2012;50(4):269.
4. Hicks CW, Sweeney DA, Cui X, et al. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med 2012;38(7):1092-1104.
5. Ng SK, Brust JC, Hauser WA, Susser M. Illicit drug use and the risk of new-onset seizures. Am J Epidemiol 1990;132(1):47-57.
6. Brust JCM. Stroke and substance abuse. In Mohr, JP, Wolf PA, Grotta JC, Moskowitz MA, Mayberg MR, von Kummer R, editors. Stroke: pathophysiology, diagnosis, and management, 5th ed. Philadelphia: Elsevier Saunders, 2011:790-813.
7. Cordova JP, Balan S, Romero J, et al. 'Chasing the dragon': new knowledge from an old practice. Am J Ther 2011 Apr 23 [Epub ahead of print].
8. Wang X, Li B, Zhou X, et al. Changes in gray matter in abstinent heroin addicts. Drug Alcohol Depend 2012 [Epub ahead of print].
9. Liu J, Liang J, Qin W, et al. Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neurosci Lett 2009;460(1): 72-77.
10. Upadhyay J, Maleki N, Potter J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 2010;133(pt 7):2098-2114.
11. Eisch AJ, Barrot M, Schad CA, et al. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 2000;97(13): 7579-7584.
12. Gibbons S. 'Legal highs'Vnovel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol 2012;50(1):15-24.
13. Miotto K, Striebel J, Cho AK, Wang C. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Dep 2013;132(1-2): 1-12.
14. Gallagher CT, Assi S, Stair JL, et al. 5,6-methlenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'. Hum Psychopharmacol Clin Exp 2012;27(2): 106-112.
15. Newsome SD, Johnson E, Pardo C, et al. Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users. Neurology 2011;76(9):787-794.
16. Petitti DB, Sidney S, Queensberry C, Bernstein A. Stroke and cocaine or amphetamine use. Epidemiology 1998;9(6):596-600.
17. Kaufman MJ, Levin JM, Ross MH, et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 1998;279(5):376-380.
18. Murphy PN,Wareing M, Fisk JE,Montgomery C. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review. Neuropsychobiology 2009;60(3-4):159-175.
19. deWin MM, Jager G, Booij J, et al. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 2008;131(pt 11):2936-2945.
20. Kish SJ, Lerch J, Furukawa Y, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain 2010;133(pt 6): 1779-1797.
21. McCann UD, Sgambati FP, Schwartz AR, Ricaurte GA. Sleep apnea in young abstinent recreational MDMA (''ecstasy'') consumers. Neurology 2009;73(23):2011-2017.
22. Lucantonio F, Stalnaker TA, Shaham Y, et al. The impact of orbitofrontal dysfunction on cocaine addiction. Nat Neurosci 2012;15(3): 358-366.
23. Narayana PA, Ahobila-Vajjula P, Ramu J, et al. Diffusion tensor imaging of cocaine-treated rodents. Psychiatry Res 2009;171(3):242-251.
24. Tau GZ, Marsh R, Torres-Sanchez T, et al. Neural correlates of reward-based learning in persons with cocaine dependence. Neuropsychopharmacology 2013, Aug 6 [Epub ahead of print].
25. Sudai E, Croitoru O, Shaldubina A, et al. High cocaine dosage decreases neurogenesis in the hippocampus and impairs working memory. Addict Biol 2011;16(2):251-260.
26. Stepens A, Groma V, Skuja S, et al. The outcome of the movements disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology. Eur J Neurol 2014;21:199-205.
27. Rousette FF, Bramen JE, Nunez SC, et al. Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse: the effects ofmethamphetamine, alcohol, and polydrug exposure. Neuroimage 2011;54(4):3067-3075.
28. Cloak CC, Ernst T, Fujii LL, et al. Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 2009;72(24):2068- 2075.
29. Thompson VB, Heiman J, Chambers JB, et al. Long-term behavioral consequences of prenatal MDMA exposure. Physiol Behav 2009;96(4-5):593-601.
30. Liu J, Lester BM, Neyzi N, et al. Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr 2013;167(4):348-354.
31. Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis 2010;29(2):245-258.
32. Lane SD, Steinberg JL, Ma L, et al. Diffusion tensor imaging and decision making in cocaine dependence. PLoS One 2010;5(7): e11591.
33. Lambert BL, Bauer CR. Developmental and behavioral consequences of prenatal cocaine exposure: a review. J Perinatol 2012;32(11):819-828.
34. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012;39(2):234-243.
35. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 2005;26(2):480-492.
36. Jager G, Van Hell HH, De Win MM, et al. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 2007;17(4):289-297.
37. Chang L, Yakupov R, Cloak C, Ernst T. Marijuana is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 2006;129(pt 5):1096-1112.
38. Lorinzetti V, Lubman DI, Whittle S, et al. Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse 2010;45(11):1787- 1808.
39. Cousijn J, Wiers RW, Ridderinkhof KR, et al. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012;59(4):3845-3851.
40. Ashtari M, Cervellione K, Cottone J, et al. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res 2009;43(3): 189-204.
41. Zalesky A, Solowij N, Yucel M, et al. Effect of long-term cannabis on axonal connectivity. Brain 2012;135(pt 7):2245-2255.
42. Brust JC. Cognition and cannabis: from anecdote to advanced technology. Brain 2012;135(pt 7):2004-2005.
43. Le Bec PY, Fatseas M, Denis C, et al. Cannabis and psychosis: search for a causal link through a critical and systematic review. Encephale 2009;35(4):377-385.
44. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol Teratol 2006;28(2): 286-295.
45. Wolff V, Armspach JP, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke 2013;44(2):558-563.
46. Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 2007;64(4):495-502.
47. Mittleman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation 2001;103(23):2805-2809.
48. Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 2011;42(6):1778-1780.
49. Wojtowicz JM, Yarema MC, Wax PM. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol, and gamma-butyrolactone: a case report and systematic review. CJEM 2008;10(1):69-74.
50. Ranganathan M., SchnakenbergA, Skolsnik PD, et al. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the 0 opioid agonist Salvinorin A in humans. Biol Psychiatry 2012;72(10):871-879.
51. Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011;49(8):705-719.
52. Hermle L, Simon M, Ruchsow M, Geppert M. Hallucinogen-persisting perception disorder. Ther Adv Psychopharmacol 2012;2(5):199-205.
53. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, et al. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23(6):611-614.
54. Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol 1989;8(4):293-300.
55. Heyer EJ, Simpson DM, Bodis-Wollner I, et al. Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology 1986;36:1618-1622.
56. Hunter L, Gordge L, Dargan P, Wood DM. Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review. Br J Clin Pharmacol 2011;72(1):18-26.
57. Maruff P, Burns CB, Tyler P, et al. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998;121: 1903-1917.
58. Wilkins-Haug L. Teratogen update: toluene. Teratology 1997;55(2):145-151.
59. Majlesi N, Lee DC, Ali SS. Dextromethorphan abuse masquerading as a recurrent seizure disorder. Pediatr Emerg Care 2011;27(3): 210-211.
60. Corazza O, Schifano F, Simonato P, et al. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 2012;27(2):145-149.
61. McCarron MM, Schultze B, Thompson GA, et al. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981;10(6):290-297.
62. Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 2012;38(5):958-966.
63. Bessen HA. Intracranial hemorrhage associated with phencyclidine abuse. JAMA 1982;248(5):585-586.